Literature DB >> 3919055

Addition of NaCl to MS-2 system clinical cuvettes for combined salt tolerance and susceptibility testing for group D streptococci.

E G Nice, L L Stone, J J Fenton.   

Abstract

Sodium chloride was added directly to individual wells of MS-2 system clinical cuvettes for evaluating the feasibility of simultaneous susceptibility and salt tolerance testing for group D streptococcal isolates. Salt tolerance was correctly detected for all 177 enterococci tested; there was no false-positive results for 29 group D nonenterococcal or 45 viridans streptococcal isolates.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3919055      PMCID: PMC271623          DOI: 10.1128/jcm.21.2.247-248.1985

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  5 in total

1.  Presumptive identification of enterococci from other D streptococci by a rapid sodium chloride tolerance test.

Authors:  S M Qadri; M J deSilva; S G Qadri; A Villarreal
Journal:  Med Microbiol Immunol       Date:  1979-08       Impact factor: 3.402

2.  Rapid identification of enterococci.

Authors:  L H Brown; E M Peterson; L M de la Maza
Journal:  J Clin Microbiol       Date:  1983-02       Impact factor: 5.948

3.  Rapid determination of novobiocin resistance of coagulase-negative staphylococci with the MS-2 system.

Authors:  R J Almeida; J H Jorgensen
Journal:  J Clin Microbiol       Date:  1983-03       Impact factor: 5.948

4.  Reliability of the MS-2 system in detecting methicillin-resistant Staphylococcus aureus.

Authors:  J M Boyce; R L White; M C Bonner; W R Lockwood
Journal:  J Clin Microbiol       Date:  1982-02       Impact factor: 5.948

5.  False-susceptible results from the MS-2 system used for testing resistant Pseudomonas aeruginosa against two third-generation cephalosporins, moxalactam and cefotaxime.

Authors:  L L Stone; D L Jungkind
Journal:  J Clin Microbiol       Date:  1983-08       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.